Medicine and Dentistry
Lutetium 177
100%
Patient
87%
Combination Therapy
78%
Absorbed Dose
67%
Dosimetry
65%
Therapeutic Procedure
62%
Kidney
49%
Radionuclide Therapy
49%
Peptide Receptor
44%
Neoplasm
40%
Toxicity
35%
Organ
32%
Cells
32%
Radiation
27%
Survival
23%
Somatostatin Receptor
22%
Liver
21%
Injection
21%
Prostate Cancer
20%
Yttrium 90
19%
Radiopharmaceutical Agent
19%
Evaluation Study
18%
Biodistribution
18%
Ligand
16%
Radiation Biology
16%
Gastrin Releasing Peptide Receptor
16%
Tetraxetan
16%
Microsphere
15%
Nuclear Medicine
15%
Lesion
15%
Radioisotope
15%
Albumin
14%
Radioligand
14%
Indium 111
13%
PET-CT
13%
Diagnosis
13%
Magnetic Resonance Imaging
12%
Peptide
12%
Prostate Specific Membrane Antigen
12%
Bone Marrow
12%
Xenograft
12%
Drug Dose Regimen
11%
Woman
11%
Thyroid Cancer
11%
Zirconium 89
11%
Adverse Event
11%
Hormone
11%
Radioembolization
10%
Gallium 68
9%
Man
9%
Pharmacology, Toxicology and Pharmaceutical Science
Lutetium 177
87%
Neoplasm
30%
Toxicity
26%
Prostate Specific Membrane Antigen
25%
Yttrium 90
24%
Survival
23%
Radiation
23%
Ligand
21%
Somatostatin Receptor
19%
Radiopharmaceutical Agent
19%
Radioisotope
18%
Mouse
17%
Gastrin Releasing Peptide Receptor
16%
Biodistribution
16%
Metastasis
16%
Antagonist
15%
Indium 111
14%
Neuroendocrine Tumor
13%
Prostate Cancer
13%
Peptide
12%
Microsphere
12%
Dosimetry
11%
Biological Product
11%
Thyroid Cancer
11%
Zirconium 89
11%
Enalapril Maleate
9%
Actinium 225
9%
Radioligand
9%
Organ Toxicity
8%
Tracer
8%
Gallium 68
8%
Animal
8%
Technetium 99m
7%
Fluorodeoxyglucose F 18
7%
Malignant Neoplasm
7%
Clinical Trial
7%
Meningioma
7%
Thrombocytopenia
6%
Nephrotoxicity
6%
Tumor Growth
6%
Adverse Event
5%
Cholecystokinin B Receptor
5%
Tetraxetan
5%
Carbonyl Derivative
5%
Cyclohexane
5%
Preclinical Study
5%
Nursing and Health Professions
Dosimetry
31%
Absorbed Dose
28%
Combination Therapy
21%
Procedures
16%
Lutetium 177
13%
Dose
12%
Neoplasm
11%
Yttrium 90
11%
Nuclear Magnetic Resonance Imaging
11%
Time
10%
Standard
10%
Radioembolization
10%
Patient
10%
Survival
8%
Evaluation Study
8%
Technetium-99m
7%
Tomography
6%
Volume
5%
Toxicity
5%
Radiation Dose Distribution
5%